SEGMENTS (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($) Facility	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) Segment	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)
Segment Reporting Information [Abstract]
Number of FDA-licensed plasma collection facilities | Facility	10
Number of operating segments | Segment			2
Revenues	$ 119,839	$ 67,275	$ 308,905	$ 184,311
Cost of product revenue	60,180	42,622	152,685	126,455
Income (loss) from operations	39,638	8,685	100,660	7,399
Interest and other (expense) income, net	(2,889)	(6,120)	(9,659)	(17,993)
INCOME (LOSS) BEFORE INCOME TAXES	36,749	2,565	91,001	(10,594)
Capital expenditures			5,469	3,574
Depreciation and amortization expense	1,940	2,093	6,101	6,223
Total assets	390,618	348,997	390,618	348,997	$ 329,182
United States [Member]
Segment Reporting Information [Abstract]
Revenues	114,748	64,618	295,465	173,920
International [Member]
Segment Reporting Information [Abstract]
Revenues	5,091	2,657	13,440	10,391
Corporate [Member]
Segment Reporting Information [Abstract]
Revenues	36	36	107	107
Cost of product revenue	0	0	0	0
Income (loss) from operations	(6,954)	(5,649)	(19,049)	(16,149)
Interest and other (expense) income, net	(2,835)	(5,979)	(9,560)	(17,823)
INCOME (LOSS) BEFORE INCOME TAXES	(9,789)	(11,628)	(28,609)	(33,972)
Capital expenditures			0	0
Depreciation and amortization expense	0	0	0	0
Total assets	90,971	50,821	90,971	50,821
Operating Segments [Member] | ADMA BioManufacturing [Member]
Segment Reporting Information [Abstract]
Revenues	113,088	66,567	299,385	175,905
Cost of product revenue	52,731	41,734	142,193	118,708
Income (loss) from operations	48,347	15,017	123,756	26,577
Interest and other (expense) income, net	(54)	(141)	(95)	(170)
INCOME (LOSS) BEFORE INCOME TAXES	48,293	14,876	123,661	26,407
Capital expenditures			5,364	1,768
Depreciation and amortization expense	1,138	1,282	3,686	3,857
Total assets	266,456	262,554	266,456	262,554
Operating Segments [Member] | Plasma Collection Centers [Member]
Segment Reporting Information [Abstract]
Revenues	6,715	672	9,413	8,299
Cost of product revenue	7,449	888	10,492	7,747
Income (loss) from operations	(1,755)	(683)	(4,047)	(3,029)
Interest and other (expense) income, net	0	0	(4)	0
INCOME (LOSS) BEFORE INCOME TAXES	(1,755)	(683)	(4,051)	(3,029)
Capital expenditures			105	1,806
Depreciation and amortization expense	802	811	2,415	2,366
Total assets	$ 33,191	$ 35,622	$ 33,191	$ 35,622